2007Junshi Yixue Kexueyuan yuankanRequires access

Dynamic changes of laboratory indexes in the chronic hepatitis B patients treated with lamivudine

Xiao Liu

Open publisher page 0 citations

Abstract

Objective: To observe the dynamic changes of laboratory indexes in the chronic hepatitis B patients treated with lamivudine. Methods:986 cases of chronic hepatitis B paticnts were enrolled. 786 of them were treated with lamivudine (100 mg/d)and 200 served as control group without treatment with lamivudine. HBV-DNA, HBV-M and liver function were examinated. Results: After one-year therapy, HBV-DNA in 391 cases of treatment group turned negative(104 cps/ml)(49.7%)and 8 cases of control group turned negative (4%)(P0.01).Abnormal ALT and AST in 703 of 786 cases of treatment group turned normal(89.4%)(P0.01). HBeAg in 84 cases of treatment group turned to anti-HBe positive(19.2%)and HBeAg in 62 cases turned negative(14.2%).In control group,HBeAg of 5 cases turned negative and anti-HBe appeared(4.2%).Conclusion:Lamivudine could inhibit the replication of HBV effectively, decrease level of ALT and AST, promote conversion of HBeAg into anti-HBe.

About this research paper

What this paper is about

Objective: To observe the dynamic changes of laboratory indexes in the chronic hepatitis B patients treated with lamivudine. Methods:986 cases of chronic hepatitis B paticnts were enrolled. 786 of them were treated with lamivudine (100 mg/d)and 200 served as control group without treatment with lamivudine. HBV-DNA, HBV-M and liver function were examinated. Results: After one-year therapy, HBV-DNA in 391 cases of treatment group turned negative(104 cps/ml)(49.7%)and 8 cases of control group turned negative (4%)(P0.01).Abnormal ALT and AST in 703 of 786 cases of treatment group turned normal(89.4%)(P0.01). HBeAg in 84 cases of treatment group turned to anti-HBe positive(19.2%)and HBeAg in 62 cases turned negative(14.2%).In control group,HBeAg of 5 cases turned negative and anti-HBe appeared(4.2%).Conclusion:Lamivudine could inhibit the replication of HBV effectively, decrease level of ALT and AST, promote conversion of HBeAg into anti-HBe.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To observe the dynamic changes of laboratory indexes in the chronic hepatitis B patients treated with lamivudine. Methods:986 cases of chronic hepatitis B paticnts were enrolled. 786 of them were treated with lamivudine (100 mg/d)and 200 served as control group without treatment with lamivudine. HBV-DNA, HBV-M and liver function were examinated. Results: After one-year therapy, HBV-DNA in 391 cases of treatment group turned negative(104 cps/ml)(49.7%)and 8 cases of control group turned negative (4%)(P0.01).Abnormal ALT and AST in 703 of 786 cases of treatment group turned normal(89.4%)(P0.01). HBeAg in 84 cases of treatment group turned to anti-HBe positive(19.2%)and HBeAg in 62 cases turned negative(14.2%).In control group,HBeAg of 5 cases turned negative and anti-HBe appeared(4.2%).Conclusion:Lamivudine could inhibit the replication of HBV effectively, decrease level of ALT and AST, promote conversion of HBeAg into anti-HBe.

Key concepts: Lamivudine, HBeAg, Chronic hepatitis, Gastroenterology, Medicine, Internal medicine, Hepatitis B, Liver function

Related papers

Back to paper searchBrowse research topicsOriginal source
Dynamic changes of laboratory indexes in the chronic hepatitis B patients treated with lamivudine — Research Paper | ScholarLens